Following non-submission
AWMSG advice |
||
| Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, hydrocortisone MR (Plenadren®) cannot be endorsed for use within NHS Wales for the treatment of adrenal insufficiency in adults. |
||
|
||
Medicine details |
||
| Medicine name | hydrocortisone MR (Plenadren®) | |
| Formulation | Modified-release tablet | |
| Reference number | 1039 | |
| Indication | Treatment of adrenal insufficiency in adults |
|
| Company | ViroPharma Ltd | |
| BNF chapter | Endocrine system | |
| Submission type | Non-submission | |
| Status | Not endorsed (Statement of Advice) | |
| Date of issue | 08/03/2012 | |